All I will say is that as a share holder in a publicly listed company, we all have a right to expect a level playing field.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025